These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 7521834)

  • 21. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uveitis associated with rifabutin treatment. Apropos of 3 patients].
    Chevalley GF; Kaiser L; Bouchenaki N; Baglivo E; Kress O
    Klin Monbl Augenheilkd; 1995 May; 206(5):388-90. PubMed ID: 7609395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
    Dautzenberg B
    Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifabutin levels may increase with fluconazole during MAC treatment.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361528
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic options for the management and prevention of Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome.
    Tartaglione TA
    Pharmacotherapy; 1996; 16(2):171-82. PubMed ID: 8820462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disseminated infection with Mycobacterium avium complex (MAC) in HIV infection].
    Fätkenheuer G; Salzberger B; Diehl V
    Med Klin (Munich); 1998 Jun; 93(6):360-4. PubMed ID: 9662943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
    Wallace RJ; Brown BA; Griffith DE; Girard W; Tanaka K
    J Infect Dis; 1995 Mar; 171(3):747-50. PubMed ID: 7876634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifabutin therapy for disseminated Mycobacterium avium complex infection.
    Sullam PM
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S37-41; discussion S41-2. PubMed ID: 8785255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute hypopyon uveitis with rifabutin therapy of systemic Mycobacterium avium complex (MAC) infection in AIDS].
    Schaller UC; Michl G; Goebel FD; Klauss V
    Ophthalmologe; 1999 Apr; 96(4):267-9. PubMed ID: 10409856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uveitis associated with rifabutin therapy: a clinical alert.
    Petrowski JT
    J Am Optom Assoc; 1996 Nov; 67(11):693-6. PubMed ID: 8979664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens.
    Chaisson RE
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S61-6; discussion S66-9. PubMed ID: 8785259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection.
    Hoy JF; Marriott D; Gottlieb T
    Med J Aust; 1996 May; 164(9):543-5. PubMed ID: 8649292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifabutin in the treatment of Mycobacterium avium complex infection: experience in Europe.
    Dautzenberg B
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S33-6. PubMed ID: 8785254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting.
    Mandigo K; Hogg RS; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy MV; Schechter MT; Montaner JS
    Tuber Lung Dis; 1996 Jun; 77(3):233-8. PubMed ID: 8758106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of rifabutin in Europe for the treatment of mycobacterial infection in AIDS patients.
    Dautzenberg B
    Infection; 1997; 25(1):63-6. PubMed ID: 9039546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.
    Nightingale SD; Cameron DW; Gordin FM; Sullam PM; Cohn DL; Chaisson RE; Eron LJ; Sparti PD; Bihari B; Kaufman DL
    N Engl J Med; 1993 Sep; 329(12):828-33. PubMed ID: 8179648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.